Fondation A De Rothschild — Clinical Trial Site

70 Registered trials

35 Currently recruiting

Organisation

Fondation A De Rothschild

Location

Paris, France

Identifier

ORG-100010626

Address

29 Rue Manin, 75940, France

Departments

#2103: Neurology
2500011:Ophtalmologie
304; Service d’Ophtalmologie
3202: Optalmology
7002:Neurology
75
Anesthésie Réanimation
Centre de Référence Maladies rares Maladie de WILSON
Consultation mémoire
Department of Neurology
Fondation Rothschild; Ophtalmologie
Internal Medicine
Interventional Neuroradiolology department
Médecine interne
n/a
Neurologie
Neurology
Neuroradiologie Interventionnelle
Neuroradiologue
Neurosurgery for pediatrics
Neurovasculaire
Neurovascular Unit
NRI
Ophtalmologie
ophtalmology
Ophthalmology
Pediatric neurosurgery department
Réanimation USC
Service d'ophtalmologie
service de medecine interne
Service de Neurologie
Service de Neuroradiologie interventionnelle
Service du Pr Cochereau

Clinical trials at this site (70)

Search interface

Evaluation of the safety of a strategy combining etanercept administration with repeated contrast ultrasound in patients with Alzheimer's d… Recruiting

2023-505714-19-00 Alzheimer's disease 3 2025-04-16
Immediate corticosteroid therapy and rituximab to prevent generalization in ocular myasthenia gravis: a PROBE-type multicenter, open-label, … Recruiting

2023-506656-24-00 Myasthenia gravis 5 2025-02-12
DISEASE MODIFYING THERAPIES WITHDRAWAL IN INACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS AGED 55 AND OVER: A MULTICENTRIC, RANDOMI… Recruiting

2024-513475-41-00 Multiple Sclerosis 5 2025-02-03
BevacizuMAV : Evaluation of the efficacy and safety of anti-angiogenic treatment with intravenous bevacizumab in patients with symptomatic c… Recruiting

2023-508464-30-00 cerebral arteriovenous malformations 4 2024-10-24
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients w… Recruiting

2023-507064-39-00 generalized Myasthenia Gravis 5 2024-09-26
“Randomized controlled multicenter study comparing efficacy and safety of adalimumab to that of mycophenolate mofetil in steroid dependent n… Recruiting

2023-505112-38-00 recently active non-infectious intermediate, posterior, 11 2024-07-01
A study to investigate long-term safety and tolerability of tolebrutinib in participants with multiple sclerosis Recruiting

2023-503631-18-01 Nervous system diseases 5 2024-05-20
UVB: treatment of UVeitis in Behçet’s diseases with biologic Recruiting

2024-513371-41-00 Severe uveitis of Behçet’s disease 4 2024-04-25
An Open-label Study of XEN1101 in Epilepsy Recruiting

2022-502282-24-00 Primary generalized tonic-clonic seizures 5 2024-02-14
For patients with active multiple sclerosis, impact of annual versus semi-annual infusions of ocrelizumab after 2 years of initial treatment… Recruiting

2023-505420-62-00 Multiple sclerosis 5 2023-11-09
Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) Recruiting

2022-502281-25-00 Focal Onset Seizures 5 2023-09-27
RIISC Recruiting

2024-513669-38-00 Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis 5 2023-05-17
A RANDOMIZED DOUBLE BLIND, PLACEBO-CONTROLLED NATIONAL MULTICENTER PHASE 3 TRIAL TO EVALUATE THE EFFICACY OF AZATHIOPRINE FOR THE PREVENTION… Recruiting

2022-500520-30-00 neurology 5 2023-03-01
Efficacy and Safety Study of Nipocalimab for Adults with CIDP Recruiting

2023-508425-28-00 Chronic Inflammatory Demyelinating Polyneuropathy 4 2022-10-24
CHOLINE-2 - Donepezil Versus Non-drug Treatment in Alzheimer's Disease Recruiting

2024-515038-34-00 Interest of adding donepezil to the non-medicinal care 6 2022-02-10
Avoid Anticoagulation After IntraCerebral Haemorrhage Recruiting

2024-514094-22-00 Intrecerebral Haemorrhage 5 2019-01-18
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication: BIOMEDE 2.0 Recruiting

2023-506027-29-00 Children, adolescents and adults with newly diagnosed d 5 2014-10-01
Conservative treatment of patients with retinoblastoma Recruiting

2024-517275-21-00 Retinoblastoma 4 2012-02-20
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended

2025-520809-12-00 Diabetic Macular Edema 10 2025-10-16
A study to assess efficacy and safety of efgartigimod PH20 SC in adults with ocular myasthenia gravis Ended

2024-514133-38-00 Ocular Myasthenia Gravis 5 2025-03-19
Efficacy and safety study of frexalimab (SAR441344) in adults with nonrelapsing secondary progressive multiple sclerosis Ended

2023-504359-29-01 Multiple sclerosis 5 2024-12-11
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema… Ended

2024-510944-30-00 Diabetic Macular Edema 10 2024-11-22
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants with Moderate-to-Severe Thy… Ended

2023-503669-50-00 Moderate-to-Severe Thyroid Eye Disease 5 2023-12-27
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04